NCT00488592 2021-07-12Peptide Vaccinations to Treat Patients With Low-Risk Myeloid CancersNational Institutes of Health Clinical Center (CC)Phase 2 Completed10 enrolled 7 charts
NCT00050531 2016-05-11High-Dose Gleevec Alone or in Combination With Peg-Intron and GM-CSF in Early Phase Chronic Myelogenous Leukemia (CML)M.D. Anderson Cancer CenterPhase 3 Completed94 enrolled